Karen Tashima, MDEdit My Page
Karen Tashima, MD is a professor of medicine in the Division of Infectious Diseases. She is the Director of HIV Clinical Studies and Clinical Research Site Leader of the AIDS Clinical Trials Unit at The Miriam Hospital. Dr. Tashima is the study chair of an ACTG study evaluating the effectiveness of a new strategy to treat HIV-infected persons with drug resistant virus. She is a principal investigator for studies of new medications for hepatitis C infection.
Dr. Karen Tashima received her medical degree from the College of Physicians and Surgeons at Columbia University. She trained in Internal Medicine at The Presbyterian Hospital of New York City and in Infectious Diseases at Massachusetts General Hospital in Boston. Dr. Tashima joined the Brown University Infectious Diseases faculty in 1995. She was the area's lead investigator of clinical trials using indinavir and efavirenz, which were shown to be life-saving for patients with HIV infection. The Miriam Hospital conducts NIH-sponsored AIDS Clinical Trials Group (ACTG) studies under her direction as well as pharmaceutically sponsored studies of investigative agents for HCV and HIV treatment. Dr. Tashima served as Infectious Disease Fellowship Director during 2005-2012, and mentors students, residents and fellows. Dr. Tashima is an Infectious Disease physician in Fall River (Family Healthcare Center at SSTAR) and at The Miriam Hospital and Rhode Island Hospital.
The Association of Nurses in AIDS Care Award for Outstanding Research Article Contributed to the Journal of the Association of Nurses in AIDS Care (1999)
Honored at the Annual Southeastern Massachusetts Conference for those living with HIV/AIDS and those who care for them (2002)
HIV Leadership Award as Outstanding HIV/AIDS Clinical from TheBody.com and TheBodyPRO.com (2005)
Fellow, Infectious Disease Society of America
Fellow, American College of Physicians
Member, American Medical Association
Member, International AIDS Society
Member, Rhode Island Medical Women's Association